SETDB1 and neoplasm: Moreover, SETDB1 mRNA levels were higher in tissues from NSCLC patients compared to non-tumor tissues [24,50,51], and this increase was associated with advanced grade NSCLC tumors [24], shorter overall survival in NSCLC patients [50] and shorter disease-free survival in NSCLC patients in stage I [51].